192310-93-3

Upstream product

• 13734-34-4 N-tert-butoxycarbonyl-L-phenylalanine 
• 6038-19-3 3-aminodihydrothiophen-2(3H)-one hydrochloride 

Downstream Products

• 1027398-90-8 {(S)-1-[(S)-1-(2-Oxo-tetrahydro-thiophen-3-ylcarbamoyl)-2-phenyl-ethylcarbamoyl]-2-phenyl-ethyl}-carbamic acid tert-butyl ester 
• 1027580-53-5 1H-Indole-2-carboxylic acid [(S)-1-(2-oxo-tetrahydro-thiophen-3-ylcarbamoyl)-2-phenyl-ethyl]-amide 
• 1027193-46-9 (S)-2-[3-(3,4-Dichloro-phenyl)-propionylamino]-N-(2-oxo-tetrahydro-thiophen-3-yl)-3-phenyl-propionamide 
• 192311-01-6 2-naphthoyl-L-phenylalanyl-D,L-homocysteine thiolactone 
• 1026560-20-2 (S)-N-(2-Oxo-tetrahydro-thiophen-3-yl)-2-(2-phenoxy-acetylamino)-3-phenyl-propionamide 
• 1027892-15-4 N-[(S)-1-(2-Oxo-tetrahydro-thiophen-3-ylcarbamoyl)-2-phenyl-ethyl]-isobutyramide 

Relevant academic research and scientific papers

Inhibition of peptidylglycine α-amidating monooxygenase by N-substituted homocysteine analogs

C-terminal amidation is a posttranslational modification found in many neuropeptides. Peptidylglycine α-amidating monooxygenase (PAM) catalyzes the synthesis of the biologically essential C-terminal amide from a glycine- extended precursor peptide. Report